{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:45:42Z","timestamp":1785775542305,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jctube.2026.100621","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:41:13Z","timestamp":1779900073000},"page":"100621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in Mycobacterium avium complex pulmonary disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Tomoki","family":"Teramoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jctube.2026.100621_bb0005","doi-asserted-by":"crossref","first-page":"00337","DOI":"10.1183\/23120541.00337-2024","article-title":"Laboratory-based surveillance of nontuberculous mycobacterial pulmonary disease in Japan","volume":"11","author":"Hamaguchi","year":"2025","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.jctube.2026.100621_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1513\/AnnalsATS.201303-067OC","article-title":"A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan","volume":"11","author":"Morimoto","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.jctube.2026.100621_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1513\/AnnalsATS.201806-366OC","article-title":"Epidemiology of adults and children treated for nontuberculous mycobacterial pulmonary disease in Japan","volume":"16","author":"Izumi","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.jctube.2026.100621_bb0020","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccm.2023.08.012","article-title":"Global epidemiology of nontuberculous mycobacterial pulmonary disease: a review","volume":"44","author":"Prevots","year":"2023","journal-title":"Clin Chest Med"},{"issue":"6","key":"10.1016\/j.jctube.2026.100621_bb0025","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan","volume":"22","author":"Namkoong","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.jctube.2026.100621_bb0030","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jctube.2026.100621_bb0035","first-page":"177","article-title":"Consensus statement on chemotherapy for adult pulmonary nontuberculous mycobacteriosis","volume":"98","author":"Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis","year":"2023","journal-title":"Kekkaku"},{"issue":"1","key":"10.1016\/j.jctube.2026.100621_bb0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.rmed.2006.04.002","article-title":"A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease","volume":"101","author":"Kobashi","year":"2007","journal-title":"Respir Med"},{"issue":"Suppl. 2","key":"10.1016\/j.jctube.2026.100621_bb0045","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jctube.2026.100621_bb0050","doi-asserted-by":"crossref","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","article-title":"Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement","volume":"51","author":"van Ingen","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jctube.2026.100621_bb0055","series-title":"Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes","author":"Clinical and Laboratory Standard Institute (CLSI)","year":"2018"},{"key":"10.1016\/j.jctube.2026.100621_bb0060","series-title":"Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes","author":"Clinical and Laboratory Standard Institute (CLSI)","year":"2023"},{"issue":"3","key":"10.1016\/j.jctube.2026.100621_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04741-22","article-title":"Comparison of treatment outcomes of cavitary Mycobacterium avium complex pulmonary disease with streptomycin or amikacin use","volume":"11","author":"Kim","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.jctube.2026.100621_bb0070","doi-asserted-by":"crossref","first-page":"21133","DOI":"10.1038\/s41598-024-71971-6","article-title":"Significance of changes in cavity after treatment in Mycobacterium avium complex pulmonary disease","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jctube.2026.100621_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/14622416.6.1.27","article-title":"Genetic factors in aminoglycoside toxicity","volume":"6","author":"Fischel-Ghodsian","year":"2005","journal-title":"Pharmacogenomics"},{"issue":"11","key":"10.1016\/j.jctube.2026.100621_bb0080","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/cid\/ciy804","article-title":"Association between duration of aminoglycoside treatment and outcome of cavitary Mycobacterium avium complex lung disease","volume":"68","author":"Kim","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jctube.2026.100621_bb0085","article-title":"Challenges in achieving the guideline-recommended amikacin level for Mycobacterium avium complex pulmonary disease","volume":"39","author":"Akutsu","year":"2025","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jctube.2026.100621_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2026.108708","article-title":"Amikacin exposure and its association with ototoxicity and efficacy in nontuberculous mycobacterial pulmonary disease treatment","volume":"253","author":"Watanabe","year":"2026","journal-title":"Respir Med"},{"key":"10.1016\/j.jctube.2026.100621_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-14-542","article-title":"Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss","volume":"14","author":"Modongo","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.jctube.2026.100621_bb0100","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/ph16101353","article-title":"Aminoglycosides-related ototoxicity: mechanisms, risk factors, and prevention in pediatric patients","volume":"16","author":"Rivetti","year":"2023","journal-title":"Pharmaceuticals"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579426000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579426000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:55:53Z","timestamp":1785772553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579426000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"alternative-id":["S2405579426000434"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2026.100621","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in Mycobacterium avium complex pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2026.100621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100621"}}